Association of AKT expression with degree of pathologic response in patients with esophageal cancer undergoing neoadjuvant therapy.

被引：1
|
作者：
Saeed, Nadia
Doepker, Matthew
Shridhar, Ravi
Weber, Jill
Hoffe, Sarah E.
Almhanna, Khaldoun
Meredith, Kenneth L.
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiat Oncol, Tampa, FL 33682 USA
[3] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.89
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
89
引用
收藏
页数：1
相关论文
共 50 条
  • [1] THE BIMODAL ASSOCIATION BETWEEN PATHOLOGIC COMPLETE RESPONSE AND TUMOR HEIGHT IN LOCALLY ADVANCED RECTAL CANCER PATIENTS UNDERGOING NEOADJUVANT THERAPY.
    Patel, S.
    Smith, J.
    Nash, G.
    Guillem, L. Temple J.
    Paty, P.
    Garcia-Aguilar, J.
    Weiser, M.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E211 - E212
  • [2] AKT Expression is Associated With Degree of Pathologic Response in Adenocarcinoma of the Esophagus Treated With Neoadjuvant Therapy
    Yamamoto, Maki
    Weber, Jill
    Shridhar, Ravi
    Hoffe, Sarah
    Almhanna, Khaldoun
    Karl, Richard
    Meredith, Ken L.
    GASTROENTEROLOGY, 2012, 142 (05) : S1109 - S1109
  • [3] AKT expression is associated with degree of pathologic response in adenocarcinoma of the esophagus treated with neoadjuvant therapy
    Saeed, Nadia
    Shridhar, Ravi
    Hoffe, Sarah
    Almhanna, Khaldoun
    Meredith, Kenneth L.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (02) : 158 - 165
  • [4] Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal Cancer
    Meredith, Kenneth L.
    Weber, Jill M.
    Turaga, Kiran K.
    Siegel, Erin M.
    McLoughlin, Jim
    Hoffe, Sarah
    Marcovalerio, Melis
    Shah, Nilay
    Kelley, Scott
    Karl, Richard
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (04) : 1159 - 1167
  • [5] Survivin expression in esophageal cancer: Association with histomorphological response to neoadjuvant therapy and prognosis
    Vallboehmer, D.
    Kuhn, E.
    Brabender, J.
    Metzger, R.
    Warnecke-Eberz, U.
    Baldus, S. E.
    Drebber, U.
    Holscher, A. H.
    Schneider, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Association of specific gene expression profiles with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinoma.
    McLaren, Patrick James
    Barnes, Anthony P.
    Terrell, Willy Z.
    Vaccaro, Gina M.
    Wiedrick, Jack
    Hunter, John G.
    Dolan, James P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [7] Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer
    Wiesel, Ory
    Zlotnik, Oran
    Morgenstern, Sarah
    Tsur, Maya
    Menasherov, Nikolai
    Feferman, Yael
    Ben-Aharon, Irit
    Kashtan, Hanoch
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (12): : 514 - 518
  • [8] Apoptosis and proliferation in esophageal cancer and their role in determining response to neoadjuvant therapy.
    Beardsmore, DM
    Verbeke, C
    Davies, C
    Bowrey, DJ
    Guillou, PJ
    Clark, GW
    GASTROENTEROLOGY, 2002, 123 (01) : 1 - 1
  • [9] Is There a Pattern for Pathologic Complete Response in Gastric Cancer Undergoing Neoadjuvant Therapy?
    Schaefer, Kenzie L.
    Brown, Sacha D.
    Hsu, Chiu-Hsieh
    Khreiss, Mohammad
    Riall, Taylor S.
    Arrington, Amanda K.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S238 - S238
  • [10] Utility of esophageal stenting for esophageal cancer patients with dysphagia undergoing neoadjuvant therapy
    Brown, R. E.
    St Hill, C. R.
    Harkenrider, M. M.
    Ellis, S.
    Sharma, V. R.
    El-Ghamry, M. N.
    Scoggins, C. R.
    McMasters, K. M.
    Abbas, A. E.
    Martin, R. C., II
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
12345